Abstract
Increasing antibiotic resistance has led to an urgent need for new therapeutic approaches. Host defense peptides are known to be antimicrobial and have revealed broad immunomodulatory functions for both innate and adaptive immunity. This review will focus on the role of host defense peptides in infection and immune response and discuss its potential and limitations as a future therapeutical agent.
Keywords: Host defense peptides, bacterial infection, innate immune system, defensins, cathelicidins, munomodulation, anitbacterial activity
Protein & Peptide Letters
Title: Host Defense Peptides and the New Line of Defence Against Multiresistant Infections
Volume: 15 Issue: 3
Author(s): Lars Steinstraesser, Tobias Hirsch, Frank Jacobsen and Hans-Ulrich Steinau
Affiliation:
Keywords: Host defense peptides, bacterial infection, innate immune system, defensins, cathelicidins, munomodulation, anitbacterial activity
Abstract: Increasing antibiotic resistance has led to an urgent need for new therapeutic approaches. Host defense peptides are known to be antimicrobial and have revealed broad immunomodulatory functions for both innate and adaptive immunity. This review will focus on the role of host defense peptides in infection and immune response and discuss its potential and limitations as a future therapeutical agent.
Export Options
About this article
Cite this article as:
Steinstraesser Lars, Hirsch Tobias, Jacobsen Frank and Steinau Hans-Ulrich, Host Defense Peptides and the New Line of Defence Against Multiresistant Infections, Protein & Peptide Letters 2008; 15 (3) . https://dx.doi.org/10.2174/092986608783744252
DOI https://dx.doi.org/10.2174/092986608783744252 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Changes of Expression of the Protein C Pathway Components in LPSInduced Endotoxemia–Implication for Sepsis
Cardiovascular & Hematological Disorders-Drug Targets Reviving an Old HIV-1 Gene: The HIV-1 Antisense Protein
Current HIV Research The Roles of Mesenchymal Stem Cells in Tissue Repair and Disease Modification
Current Stem Cell Research & Therapy Radix Astragali (Astragalus): Latest Advancements and Trends in Chemistry, Analysis, Pharmacology and Pharmacokinetics
Current Organic Chemistry About the Guest Editors
Recent Patents on Inflammation & Allergy Drug Discovery Patent Selections
Recent Patents on Cardiovascular Drug Discovery Editorial (Hot Topic: Treatment of Atherosclerosis as an Inflammatory Disease)
Current Pharmaceutical Design Development of Tissue Engineered Vascular Grafts
Current Pharmaceutical Biotechnology Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific
Current Drug Metabolism Monoclonal Antibodies: A Target Therapy for Multiple Sclerosis
Inflammation & Allergy - Drug Targets (Discontinued) In-Vitro Assessment and Pharmacodynamics of Nimesulide Incorporated Aloe vera Transemulgel
Current Drug Discovery Technologies Bone Health in Juvenile-Onset Systemic Lupus Erythematosus
Current Rheumatology Reviews FTY720: A Most Promising Immunosuppressant Modulating Immune Cell Functions
Mini-Reviews in Medicinal Chemistry Mucosal Healing in Ulcerative Colitis: Where do we Stand?
Current Drug Targets MAP Kinase p38Inhibitors: Clinical Results and an Intimate Look at Their Interactions with p38α Protein
Current Medicinal Chemistry Lipid-based Self-Adjuvanting Vaccines
Current Drug Delivery Evaluation of Pregabalin Therapy in Peripheral Neuropathy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Host Background Factors Contributing to Hepatitis C Virus Clearance
Current Pharmaceutical Biotechnology AMPK: Therapeutic Target for Diabetes and Cancer Prevention
Current Pharmaceutical Design Inflammatory Biomarkers and Cardiovascular Risk Assessment. Current Knowledge and Future Perspectives
Current Pharmaceutical Design